SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-09-003832
Filing Date
2009-04-06
Accepted
2009-04-06 10:09:56
Documents
5
Period of Report
2009-05-05
Effectiveness Date
2009-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2191885zdef14a.htm DEF 14A 701318
2 G456475.JPG g456475.jpg GRAPHIC 7640
3 G21452BAI001.JPG g21452bai001.jpg GRAPHIC 748
4 G21452BAI002.JPG g21452bai002.jpg GRAPHIC 710
5 G21452BAI003.JPG g21452bai003.jpg GRAPHIC 663
  Complete submission text file 0001047469-09-003832.txt   716905
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-14732 | Film No.: 09734053
SIC: 2835 In Vitro & In Vivo Diagnostic Substances